4th Cancer Targets and Therapeutics
25 Feb 2013 - 26 Feb 2013 - Las Vegas, NV, USA
With the rapid progression of molecular biology and genetics, and the subsequent emergence of many new targets, emerging targets & therapeutics provides new opportunities for the prevention and treatment of several major disease systems. The 4th Cancer Targets & Therapeutics Conference, taking place on February 25-26, 2013 in Las Vegas, NV, examines new and emerging targets and therapeutics in the area of cancer research. Speakers at the event provide case studies in order to address some of the issues surrounding target-based drug discovery and development.
Preliminary Sessions for 2013 Agenda:
-Novel Kinase Inhibitors & Beyond the Kinome
-Functional Genomics & Future Cancer targets
-Novel Antibody-based Modalities
-Progress in Cancer Immunotherapy
-Cancer Stem Cells, Metabolism, Cancer Epigenetics
-Patient Selection Rationale & Strategy
This conference is part of our 2nd Novel Cancer Therapeutics Summit which consists of two other concurrent conferences shown below:
2nd Novel Cancer Therapeutics Summit:
Track: 4th Cancer Targets & Therapeutics
Track: 2nd Oncology Partnering & Deal-making
Track: 3rd Ubiquitin Research & Drug Discovery
Sign up for the Summit Pass to have access to all tracks of the summit!
Call for Papers!
To be considered for an oral presentation, please submit an abstract here by January 25, 2013. Selected presentations will be based on quality of abstract and availability. Presentation slots fill up fast so please submit your abstract ASAP.
Sponsorship and exhibiting opportunities are available in a range of levels, which can be tailored to fit your needs. Please contact 626-256-6405 x102 or firstname.lastname@example.org for more information.